NM_016239.4:c.4310A>G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_016239.4(MYO15A):āc.4310A>Gā(p.Tyr1437Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,611,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 246288Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 133992
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1459016Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 725994
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74360
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:2
- -
- -
not provided Pathogenic:1
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1437 of the MYO15A protein (p.Tyr1437Cys). This variant is present in population databases (no rsID available, gnomAD 0.02%). This missense change has been observed in individual(s) with deafness (PMID: 26969326, 32279305, 35346193, 35580552). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 517638). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO15A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Tyr1437Cy s variant in MYO15A has been previously reported in two individuals with hearing loss (LMM data, Sloan-Heggen 2016). One individual also harbored a pathogenic t runcating MYO15A variant (LMM data), and one individual harbored a second varian t of uncertain significance in MYO15A (Sloan-Heggen 2016). Phasing was not perfo rmed for either individual. This variant has been identified in 0.02% (3/15418) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computation al prediction tools and conservation analysis suggest that the variant may impac t the protein, though this information is not predictive enough to determine pat hogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Tyr1437Cys variant is uncertain. ACMG/AMP Criter ia applied: PM2; PP3; PM3_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at